原料供應 │ 代工生產 │ 倍乘®配方
最多選擇 │ 最多功能 │ 最多應用
創百專利技術升級後生元
「成就益源質® 讓好菌更好」
讓後生元的腸道菌相恢復力，提升 53.4%
讓後生元的保護力，提升 98.3%
讓後生元的保護力因子，增加 29.3%
讓後生元改善腸道菌叢的能力，提升 3 倍
讓後生元提升穩定性，通過胃酸保護力不減
獨家專利組合益生聯®
好菌+益生元+專利後生元 ( 益源質® )
倍乘®科學，讓效果1+1+1>3
改善腸道菌叢的能力，提升 15 倍
有效抑制壞菌生長
保護力強 7.7 倍
專利增強型後生元+活菌，通過胃酸後，其保護力效果依舊極佳，甚至比未通過胃酸的益生菌保護更強。
Probiogenics 益生聯®
專利申請與取得
| Patent title | Granted | Pending | |
| Taiwan | 後生元提取物的製備方法以及由該方法所得到的產物及其用於抑制生物膜形成與促進腸道健康之用途 A method for preparing postbiotic extract, and its products obtained therefrom for inhibiting biofilm formation and promoting intestinal health. | TW I733446 | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. | TW I739424 | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途 The use of postbiotic extract for promoting skin regeneration and anti-aging. | TW I748448 | ||
| 具有核殼結構的益生菌顆粒 Probiotic particles with nuclear-shell structure. | TW M602905U | ||
| 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷 The use of heat-killed Lactobacillus strains for treating and/or preventing particulate matter-induced lung injury. | TW I802009 | ||
| 使用一包含有植物乳桿菌 CB102 分離株與燕窩酸的組合來改善皮膚病況 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid for improving skin conditions. | TW I808582 | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. | TW I858748 | ||
| 具穩定包覆活性成分能力之複合結構保健品 A composite structural health supplement with the ability for stable encapsulation of active ingredients. | TW M655351 | ||
| 植物乳桿菌 CB102 的後生元萃取物及其製備方法與降低血中尿酸用途 The Preparation Method of Lactobacillus plantarum-derived Postbiotics CB-102 and Its Application in Reducing Blood Uric Acid Levels. | 113129230 | ||
| China | 後生元提取物的製法以及該方法得到的產物及其抑制生物膜形成與促進腸道健康的用途 The method of preparing postbiotic extract, the product obtained by the method, and its use for inhibiting biofilm formation and promoting intestinal health. | CN 113925158B | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. | CN 113925885B | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途 The use of postbiotic extract for promoting skin regeneration and anti-aging. | CN 113925884B | ||
| 具有核殼結構的益生菌顆粒及益生菌軟膠囊 Probiotic particles with nuclear-shell structure and probiotic soft capsules. | CN 213549547U | ||
| 熱致死的乳酸菌菌株作為製備治療和/或預防微粒物質-誘發的肺損傷的醫藥品的用途 The use of heat-killed Lactobacillus strains as a pharmaceutical preparation for the treatment and/or prevention of particulate matter-induced lung injury. | 202111291686.0 | ||
| 包含植物乳桿菌 CB102 與燕窩酸的組合在製備用來改善皮膚病況的組合物中的用途 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid in the preparation of a composition for improving skin conditions. | 202211396626.X | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. | 202310870474.0 | ||
| 植物乳桿菌 CB102 的後生元萃取物及其製備方法與降低血中尿酸用途 The Preparation Method of Lactobacillus plantarum-derived Postbiotics CB-102 and Its Application in Reducing Blood Uric Acid Levels. | 202411226243.7 | ||
| USA | POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF | US 11541085 B2 | |
| METHOD FOR ALLEVIATING ARTHRITIS WITH POSTBIOTIC EXTRACT | US 11517596 B2 | ||
| METHOD FOR IMPROVING SKIN CONDITION WITH POSTBIOTIC EXTRACT | US 11517597 B2 | ||
| METHOD FOR PREVENTING OR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY | US 12,090,182B2 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF (inhibiting biofilm formation) | US 11,931,388 B2 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF (promoting intestinal health) | US 11,925,668 B2 | ||
| METHOD OF USING A COMBINATION OF POSTBIOTICS AND PROBIOTICS FOR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION-ASSOCIATED DISORDERS. | 18/499450 |
Probiogenics 益生聯®
學術發表
| Year | Papers title | Journal/Exhibition name |
| 2023 | 後生元協同益生菌減輕由 PM2.5 引起的肺損傷及過敏 Synergistic effect of probiotic and postbiotic on attenuation of PM2.5-induced lung damage and allergic response. | J Food Sci. 2023;88(1):513-522. doi:10.1111/1750-3841.16398 |
| 久司酵素增強版透過纖維與體內油脂結合與促進排出來改善腸道健康 BraziZyme® PLUS improves gastrointestinal health through its fiber-mediated binding and excretion of intracellular lipids . | 2023 台灣乳酸菌協會研討會 2023 Taiwan Association for Lactic Acid Bacteria Conference |
益源質®/類生元®：獨特後生元 Postbiotics
L-137
專利及申請
JP 4064480, JP 4601745, JP 4064481, JP 4064515, JP 4034632, WO 2014199448 A1, EP 2177110 B, CN 101720935 B, US 20100098728 A, US 8114658 B, US20090324563 A, EP 2050434 A, WO 2008018143 A, WO 2004084923 A, WO 2004084922 A
Rice Kefiran
專利及申請
JP2002-330798A
LM-1004
專利及申請
KR101794635, KR101919938, USA-20190284522A1
益生元 (益菌生)
Lactosucrose LP-45
專利及申請
EP 0470331 B1, JP H10-4-281795, JP H10-6-228180, JP H10-7-177851, JP H10-10-57092,
JP H10-2000-41694, US 5089401 A, CA 2040877 A1, US 20080202503 A1,
WO 2006011301 A1, CA 2573774 A1, CN 1993374 A
益生菌
BORI
專利及申請
KR0492455, US 2005/0164368A, EP 1571213 A, JP2005102696A
BGN4
專利及申請
KR10-0635354, KR 0554346, KR 821266
HU58
專利及申請
EP3405041B1, US8673311B2
- You are here »
- 專利及文獻實證 »